Zoetis (ZTS) Asset Writedowns and Impairment (2012 - 2026)

Zoetis (ZTS) has reported Asset Writedowns and Impairment for 15 consecutive years, with $13.0 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Asset Writedowns and Impairment fell 31.58% year-over-year to $13.0 million in Q1 2026; TTM through Jun 2026 was $29.0 million, a 56.72% decrease from a year earlier, with the FY2025 full-year figure at $68.0 million, down 29.9% from the prior year.
• Asset Writedowns and Impairment was $13.0 million for Q1 2026 at Zoetis, down from $16.0 million in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $33.0 million in Q4 2023 and troughed at $1.0 million in Q3 2023.
• A 5-year average of $17.8 million and a median of $17.0 million in 2024 frame the typical range for Asset Writedowns and Impairment.
• Across the five-year window, Asset Writedowns and Impairment jumped 145.45% in 2022 and sank 50.0% in 2023, its largest moves.
• Over 5 years, Asset Writedowns and Impairment stood at $27.0 million in 2022, then gained by 22.22% to $33.0 million in 2023, then retreated by 21.21% to $26.0 million in 2024, then slumped by 38.46% to $16.0 million in 2025, then dropped by 18.75% to $13.0 million in 2026.
• The last three Asset Writedowns and Impairment figures came in at $13.0 million (Q1 2026), $16.0 million (Q4 2025), and $22.0 million (Q2 2025), per Business Quant data.